Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-11-002918
Filing Date
2011-11-21
Accepted
2011-11-21 12:46:00
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC. FORM 10-Q SEPTEMBER 30, 2011 signpath10q20110930.htm 10-Q 680640
2 CERTIFICATES OF DESIGNATION, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE STOC ex3-5.htm EX-3.5 55048
3 FORM OF SERIES B SUBSCRIPTION AGREEMENT ex4-6.htm EX-4.6 487507
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex31-1.htm EX-31.1 16769
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex32-1.htm EX-32.1 9578
  Complete submission text file 0001096906-11-002918.txt   2621092

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE sppxbrl-20110930.xml EX-101.INS 318797
7 XBRL SCHEMA sppxbrl-20110930.xsd EX-101.SCH 9509
8 XBRL CALCULATION sppxbrl-20110930_cal.xml EX-101.CAL 5471
9 XBRL DEFINITION sppxbrl-20110930_def.xml EX-101.DEF 41746
10 XBRL LABEL sppxbrl-20110930_lab.xml EX-101.LAB 74993
11 XBRL PRESENTATION sppxbrl-20110930_pre.xml EX-101.PRE 55620
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 111218373
SIC: 2834 Pharmaceutical Preparations